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Summary.-Fourteen of 31 patients with non-Hodgkin's lymphoma or chronic
lymphocytic leukaemia had a monoclonal immunoglobulin light chain detectable in
their urine. These chains are believed to be synthesized by the B lymphoid cells
comprising the tumour. Upon comparing the different cases, the occurrence and
amount of monoclonal light chain showed no dependence upon the extent of tumour,
the presence of leukaemic component, or exposure to cytotoxic therapy. The method
of detection involved purifying the urinary light chains by immunosorption, and
examining their electrophoretic distributions so as to distinguish between the
homogeneous monoclonal chains and their heterogeneous normal analogues.
MODERN STUDIES of the histology and
surface markers of non-Hodgkin's lymph-
oma (NHL) and chronic lymphocytic
leukaemia (CLL) indicate that most neo-
plasms in both categories arise from B
lymphoid cells (Grey et al., 1971; Hamblin
& Hough, 1977; Leech et al., 1975;
Johansson etal., 1976). The cells frequently
synthesize immunoglobulin (Ig) in small
amounts for insertion into their plasma
membranes, but typically do not export
sufficient to yield a monoclonal Ig detect-
able by electrophoretic examination of
serum (Stevenson, 1976).
In the contrasting category of B
lymphomas exporting large amounts of
Ig (multiple myeloma, Waldenstr6m's
macroglobulinaemia, heavy-chaindiseases)
the neoplastic cells often produce Ig light
chains in amounts surplus to the incor-
poration into whole Ig molecules. These
free light chains appear eventually in the
urine as Bence Jones protein, where they
can provide an index of tumour load
(Alexanian et al., 1968). Studies in vitro of
cells from NHL and CLL have revealed
that here also there is frequently a surplus
production of light chains, on a com-
mensurately small scale (Maino et al.,
47
1977; Rudders & Howard, 1977; Gordon
et al., 1978). The present study was under-
taken to assess whether Ig light chains
arising from such lymphomas in vivo are
detectable in the patients' urine and thus
available as a tumour marker.
Monoclonal Ig in serum or urine is
usually identified by virtue of its electro-
phoretic homogeneity: in sufficient con-
centration it is seen as a narrow electro-
phoretic zone superimposed on a broad
zone of normal Ig. A monoclonal urinary
light chain must be identified thus among
the 4 mg or so of normal light chains
appearing daily in urine (Hemmingsen &
Skaarup, 1975). However, it was antici-
pated, and confirmed, that monoclonal
light chain in minimal amounts would be
further obscured in a urinary electro-
phoretogram by the relatively large
amounts of non-Ig urinary proteins which
have P and y electrophoretic mobilities
(Stevenson, 1962). So our approach was to
develop a routine for separating the entire
population of urinary light chains before
examining their electrophoretic distribu-
tions. A preliminary account of this work
has already been published (Stevenson,
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PATIENTS, MATERIALS AND METHODS
Patients.-Thirty-one patients (15 CLL,
16 NHL) attending haematology andoncology
outpatient clinics at the Royal South Hants
Hospital, Southampton, and the Royal
Victoria Hospital, Bournemouth, were willing
to co-operate in collecting 24h urinary
samples. Tables I and II set out ages and sexes
and give an indication ofthe extent ofdisease.
Some patients were newly diagnosed, some
under observation. The tables indicate those
who had received or were receiving cytotoxic
drugs at the time of study.
All patients with CLL (except W.T.)
appeared to have a B-cell neoplasm by virtue
of the cells possessing surface Ig and/or C3
receptor. The lymphocytes of W.T. formed
rosettes with sheep red cells and were there-
fore probably ofT type.
The histology of NHL biopsy specimens
was reported by a number ofpathologists over
a period of about 4 years, so the descriptions
are likely to contain some inconsistencies.
Nevertheless, by the criteria of Lukes &
Collins (1975) the majority of the patients
probably had B-cell neoplasms, in view of
histology showing follicular-centre cell (FCC)
or immunoblastic characteristics. Additional
evidence for the B-cell nature of their lym-
phomas was available for Patients A.W.,
N.S., J.S. andH.W., whose bloodlymphocytes
showed surface Ig largely restricted to one
light chain type (K, A, K and K respectively):
this is consistent with most of the blood
lymphocytes representing leukaemic com-
ponents of B lymphomas.
No patient in this series had proteinuria
upon routine clinical testing, nor a mono-
clonal Ig band apparent in serum electro-
phoretograms.
Immunoglobulins, antibodies, and immuno-
sorbents.-Immunosorbents were prepared
by coupling either antigen or antibody to
Sepharose CL-4B (Pharmacia), using the
cyanogen bromide method (Porath, 1974);
10 mg protein was coupled to each cm3 of
the gel.
Bence Jones proteins were isolated from
urines of patients with multiple myeloma,
using sequential salt precipitation, ion-
exchange chromatography on DEAE-cellu-
lose, and gel filtration (Stevenson & Straus,
1968). An antiserum to K light chains was
prepared by immunizing sheep with a pool of
three K Bence Jones proteins; for the primary
injection, up to a total of 1 mg in complete
Freund adjuvant was given s.c. in the four
limbs, and for the booster 5 weeks later,
similar injections were given with the
adjuvant omitted. The animals were bled 1
and 2 weeks later. From the antiserum puri-
fied antibody was isolated by binding to a
K chain-Sepharose immunosorbent, eluting
with 0-5M NH3 at room temperature, and
returning to neutral buffer by dialysis at 4°C.
100 mg of this purified anti-K was in turn
coupled to 10 cm3 of Sepharose CL-4B to
provide an anti-K immunosorbent. An anti-A
immunosorbent was prepared by an analo-
gous sequence of steps. The capacity of each
column, in the zone of efficient extraction
from the fluid phase, was 4-5 mg of the
homologous light chain.
Antisera were raised in rabbits to urinary A
chains from two patients with CLL. In each
case 0-2 mg A chain was injected into each of
3 rabbits, divided equally between primary
and booster injections. The primary was in
complete Freund adjuvant, given s.c. into
the dorsa of the feet. The booster was in
aqueous solution, i.v. The animals were bled
one week later.
Urinary light chains.-Urine was collected
in 24h lots, directly into a bottle containing
5 ml of either toluene or chloroform as a
preservative, and was stored at -20°C until
required. Processing was also in 24h lots.
After thawing, NaCl (40 g/l) was added to
precipitate the Tamm-Horsfall glycoprotein.
Solids were then removed by passing sequen-
tially through paper (Whatman I) and glass
fibre (Millipore AP25) filters. Subsequent
steps are summarized in Fig. 1. First the
entire volume was passed through 3 immuno-
sorbent columns, each of volume 10 cm3,
connected in series. The first column was a
blank consisting ofnormal sheep IgG coupled
to Sepharose CL-4B, designed to remove any
components adheringnonspecificallytoimmu-
nosorbent matrix. The second and third
columns bound K and A light chains respec-
tively. After washing the latter columns with
buffer the bound light chains were eluted with
0-2M propionic acid, 0-02M NaCl, pH 2-8.
(This eluent was selected, after several trials,
to allow the next stage to proceed in tandem)
In order to obtain the chains at a concentra-
tion suitable for routine electrophoretic
examination (1-2 mg/ml) the acid eluates
were led directly on to0-5cm3 cation exchange
columns (Sulphopropyl-Sephadex C50, Phar-
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macia) previously equilibrated with 0-05M
sodium acetate buffer (pH 4-7); under these
conditions all light chains bind to the nega-
tively charged columns. Each column was
washed with 0-025M NaCl, 0-005M sodium
acetate buffer (pH 4.7) and then the bound
chains were eluted abruptly with 0-2M NaCl,
018M sodium barbitone buffer (pH 8-6).
Some70% ofthe eluted protein was contained
in a fraction of 0 3 ml which was used for
electrophoretic examination.
Analytical methods.-Electrophoresis was
carried out on cellulose acetate strips in the
Beckman Microzone apparatus, using 0-09M
sodium barbitone buffer (pH 8.6). Strips
stained with Ponceau-S were scanned in
a densitometer (Electrophoresis Scanner,
Camag, Multenz, Switzerland).
Precipitation reactions were carried out by
the Ouchterlony double-diffusion method in
agar. The inter-well distance was 1V5 cm and
the plates were developed in a moist atmos-
phere at room temperature.
RESULTS
The efficacy of the procedures sum-
marized in Fig. 1 was verified by testing
the detection and recovery ofBence Jones
proteins addedto normal urine. Recoveries
from the immunosorbent columns of 4 mg
added to 400 ml of urine were normally
> 70%. The lower limit for detection of
the monoclonal protein in the subsequent
electrophoretic patternis partlydependent
on the somewhat variable amounts
(Hemmingsen & Skaarup, 1975) ofnormal
light chains present to obscure the picture,
but the experiments in which Bence Jones
proteins were added to normal urines
suggested that 1-2 mg of monoclonal light
chain in a 24h urinary output should
normally be detectable. A possible alterna-
tive method for identifying monoclonal
K or A chains on a polyclonal background,
studying the shape of precipitin arcs
obtained upon immunoelectrophoresis of
concentrated urinary macromolecules, was
much less sensitive and reliable in our
hands.
Some electrophoretic patterns are repro-
duced in Fig. 2. The pattern given by the
total urinary proteins of Patient H.S.,
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FIG. 1.-Processing of urine in outline. (1)
Passage through 3 immunosorbent columns
in series, with K and A extracted by the
second and third. (2) Elution of K and A
from the columns by acid, the eluates being
led directly on to (3) Cation exchange
columns, where the positively charged
chains are bound in a small volume. (4)
Elution from the cation exchange columns
by concentrated electrophoresis buffer,
yielding K and A at suitable concentrations
and pH for electrophoretic examination.
after a simple 500-fold concentration of
his urine, shows a- and f-globulin peaks
better marked than usual, and only a
small proportion of protein in the y zone.
His isolated A chains were spread broadly
over the P and y zones at a just detectable
concentration. His K chains on the other
hand gave a sharp peak in the fast y zone,
attributed to a monoclonal chain, on a
broad base attributed to both monoclonal
and normal K chains. Normal light chains
were never seen to give the sharp peak
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FIG. 2. Some representative electrophoretic
patterns. The anode is to the left and
migration is from right to left. Examina-
tions were carried out at different times so
that alignment of the patterns for com-
paring mobilities can be approximate only.
Top: total urinary proteins of Patient H.S.,
examined in a sample concentrated 500-
fold by ultrafiltration through Visking 2"
cellophane tubing. Middle: K and A chains
purified from the urine of H.S. as depicted
in Fig. 1. The proteins were examined on
separate strips, the patterns being super-
imposed here for comparison. Bottom: K
and A chains purified from the urine of
Patient F.G., the patterns again super-
imposed for comparison.
apparent here. Note that the K peak
cannot be located amid the total urinary
proteins.
The K chains of patient F.G. gave the
largest monoclonal peak in our series.
This peak was apparent in the electro-
phoretogram of total urinary proteins, the
only case in which this was so, but was
identified with confidence only after the
separatory procedure. The A chains pre-
sent a typical broad (polyclonal) spread.
In Fig. 3 we summarize further in-
vestigation of the most equivocal electro-
phoretic result, that obtained with the
A chains of Patient C.W. Parallel results
obtained with the monoclonal A chain of
the patient M.W.(1) are included for com-
parison. The CW double A peak was
clearly abnormal, and was considered
probably to represent either electro-
phoretic heterogeneity of a monoclonal
protein resulting from some post-synthetic
degradation (Awdeh et al., 1970) or a
monoclonal protein superimposed on an
increased amount of normal A chains. To
decide whether an appreciable proportion
of CW A chains was monoclonal we
sought evidence of another characteristic
of monoclonal Ig, a predominant set of
idiotypic antigenic determinants (Capra &
Kehoe, 1975; Radl et al., 1978). A rabbit
antiserum was raised against the A chains
(see Methods) and the antiserum-antigen
reaction examined by Ouchterlony pre-
cipitin test for evidence of an idiotypic
component. In Fig. 3 it is seen that the
band of precipitate spurred over a band
given by the same antiserum with a A
Bence Jones protein ofOz isotype, a result
suggesting strongly that the CW A chains
contained a predominant idiotypic set.
(The possibility of the spur being due to
one of the rarer A isotypes (Hess et al.,
1971; Fett & Deutsch, 1975) cannot be
ruled out, but a high concentration ofsuch
an isotype would itself suggest mono-
clonality.)
The results for all our patients are
summarized in Tables I and II. The
emerging picture is that 40-50o of
patients with CLL or NHL have a mono-
clonal light chain detectable by our
method, and that there is no dependence
yet apparent on the type of disease (CLL
or NHL), extent of disease or institution
of cytotoxic therapy. Among the CLL
group all 5 patients with a urinary mono-
clonal light chain had surface Ig of the
same light-chain type detectable on their
leukaemic cells. The same is true of the
patient A.W. with NHL and a small
leukaemic overspill.
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FiGi. 3.-Investigation of an equivocal electrophoretic pattern of A chains from Patient C.W. A
parallel investigation of A chains from Patient M.W. (1) is included for comparison. Left: electro-
phoretic patterns. Right: Ouchterlony precipitin patterns. Antisera (AS) are in the middle wells,
and the peripheral wells contain the corresponding antigen (MW or CW A chains) adjoining a
purified Oz+vye Bence Jones protein (labelled "A") included for antigenic comparison. MW spurs
strongly over the Bence Jones protein, CW less strongly but still quite clearly. These spurs provide
strong confirmatory evidence of monoclonality, as discussed in the text. The CW preparation has
also yielded a faint second band of precipitation, nearer the antigen well; this is probably due to a
minute amount of contaminating A-containing IgG.
DISCUSSION
There does not appear to be any pre-
vious report of a search for monoclonal
light chains associated with lymphoma at
the level of sensitivity (1-2 mg/day) we
have chosen. Very occasional reports
(Snapper & Kahn, 1971; Virella et al.,
1975) have described Bence Jones protein-
uria of sufficient magnitude to yield a
classical heat test in association with
chronic lymphocytic leukaemia. The
amount of light chain required for posi-
tivity in this test is ofthe order of 1 g/day
(Lindstrom et al., 1968). In the presence of
such a light chain output one would wish
to be sure that the underlying tumour was
not ofthe frankly exporting variety, e.g. a
Waldenstrom's macroglobulinaemia with
a leukaemic phase. Moderate increases in
levels of urinary light chains were found
by Lindstrom et al. (1969) in 19/76 cases
of lymphoma and leukaemia, but none of
them presented evidence that the increase
was due to a monoclonal component.
As is usually the practice for serum
proteins, we have reached decisions on
monoclonality by subjective judgements
based on the shapes of electrophoretic
peaks. We feel that this should prove
adequate, bearing in mind the possible
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TABLE I.-Patients with chronic lymphocytic leukaemia
White
cell
count
(109/1)
180
43
50
240
650
25
47
16
120
65
160
84
190
35
270
Surface
Enlargement of Ig on
+leukaem ic
Lymph Cytotoxic cells
Liver Spleen nodes drugs (chains)
+ + + + ILSK
- - + - ND
_ + + - K
+ + + - 8K
_ + + + /USYK
- - + - NA
_ _ - - y/K
+ - - -YK
- + + + USA
- + + + ND
- - + + ND
+ + + - ND
+ + + - SA
_ _ + - LSK
+ + + + ILK
Urinary
monoclonal
light
chain
(type)
K
ND
ND
K
ND
ND
ND
ND
A
ND
ND
ND
A
ND
K
ND=not detected. NA =not available.
Surface Ig was detected by immunofluorescence (Hamblin & Hough, 1977).
TABLE II.-Patients with non-Hodgkin's lymphoma
Enlargement of
Lymph
Liver Spleen nodes
+ ± +
+ + +
(ascites) (ascites) +
+ + +
_- +
+ + +
+ + +
+ + +
+
Histology on biopsy*
FCC, small cleaved
FCC, small cleaved
FCC, small and large cleaved
FCC, small cleaved
NA
FCC, small cleaved, sclerosis
FCC, cleaved, Burkitt-like
FCC, small cleaved, diffuse
Lymphosarcoma
NA
NA
Histiocytic lymphoma
Immunoblastic sarcoma
(extra-dural)
FCC, well differentiated
FCC, small cleaved
Moderately differentiated
lymphocytic lymphoma
Urinary
monoclonal
light
Cytotoxic chain
drugs (type)
K
K
- ND
+ ND
+ ND
A
+ ND
- ND
K
+ A
+ ND
+ ND
+ K
- K
K
+ K
ND =not detected. NA=not available.
FCC =follicular centre cell.
* Reports from several different pathologists.
resort to demonstrating idiotypic deter-
minants after raising an antiserum.
Although laborious, more frequent use of
this method in deciding the monoclonality
of serum immunoglobulins has been rec-
ommended (Radl et al., 1978). If it is
established that a large proportion of
either the K or A content of a patient's
urine is monoclonal, it might prove
sufficient in following his progress to chart
the total output of that light-chain type,
an estimation within the scope of routine
diagnostic services.
We have yet to prove that the mono-
clonal light chains we detect in urine arise
from the patient's neoplastic lymphocytes.
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Patient
F.G.
W.F.
D.H.
H.S.
M.R.
O.W.
W.L.
L.S.
M.W. (1)
F.U.
W.T.
N.S.
C.W.
M.W. (2)
S.H.
Age
59
75
56
78
86
79
52
80
73
57
68
82
74
64
62
Sex
M
M
M
M
F
F
F
F
M
M
F
M
F
M
Patients
P.J.
A.W.
R.N.
N.S.
I.D.
R.S.
J.S.
H.W.
G.G.
R.C.
D.M.
S.D.
M.H.
Age
61
66
64
51
78
53
23
78
79
65
23
53
59
Sex
F
M
M
M
M
M
M
F
F
M
M
M
F
I.T. 55
M.P. 30
B.N. 81
M
M
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This seems overwhelmingly likely because
of demonstrations in vitro of synthesis of
surplus light chains by such cells (Maino
et al., 1977; Rudders & Howard, 1977;
Gordon et al., 1978) and because all six of
our cases in which both urinary light chain
and cell surface Jg were detected revealed
the same light chain type at both sites. A
demonstration of the same light chain
idiotype at the two sites would be
definitive.
Over the group of patients studied the
detectability of monoclonal light chains
has not reflected the extent of neoplasm,
in accord with findings in vitro that among
CLL and NHL some neoplasms synthesize
more free light chain per cell than others
(Maino et al., 1977; Gordon et al., 1978).
Variations in renal handling of free light
chains might be another relevant factor in
the clinical picture, most plasma light
chain being catabolized in the kidney
rather than excreted intact in the urine
(Solomon et al., 1964; Wochner et al.,
1967; Waldmann et al., 1972).
For those B lymphomas in which a
urinary monoclonal light chain is detected,
its level of excretion (or perhaps even its
detectability) could prove a useful index
of tumour load. This would be particu-
larly valuable for NHL, in which the
presence of some residual lymphadeno-
pathy after induction of remission can
cause uncertainty and anxiety about
resurgence of the tumour. A tumour
marker is more urgently required in such
cases than in CLL, where the blood count
is available, or multiple myeloma, where
good remissions are still uncommon.
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